127 related articles for article (PubMed ID: 1333789)
21. Soluble tumor necrosis factor (sTNF) receptors: a possible prognostic marker for bone marrow transplantation-related complications.
Or R; Kalinkovich A; Nagler A; Weisman Z; Naparstek E; Weiss L; Hahn T
Cytokines Mol Ther; 1996 Dec; 2(4):243-50. PubMed ID: 9384711
[TBL] [Abstract][Full Text] [Related]
22. High levels of sTNFR p75 and TNF alpha in dengue-infected patients.
Hober D; Delannoy AS; Benyoucef S; De Groote D; Wattré P
Microbiol Immunol; 1996; 40(8):569-73. PubMed ID: 8887351
[TBL] [Abstract][Full Text] [Related]
23. Release of soluble tumor necrosis factor receptors in Mediterranean spotted fever rickettsiosis.
Kern WV; Oristrell J; Segura-Porta F; Kern P
Clin Diagn Lab Immunol; 1996 Mar; 3(2):233-5. PubMed ID: 8991643
[TBL] [Abstract][Full Text] [Related]
24. Tumor necrosis factor-alpha and soluble tumor necrosis factor receptors in the culture supernatants of polymorphonuclear cells and peripheral blood mononuclear cells from cancer patients.
Jablońska E; Kiluk M; Piotrowski L; Grabowska Z; Markiewicz W; Jablonski J
Eur Cytokine Netw; 1998 Jun; 9(2):155-9. PubMed ID: 9681391
[TBL] [Abstract][Full Text] [Related]
25. Release of soluble receptors for tumor necrosis factor in clinical sepsis and experimental endotoxemia.
van der Poll T; Jansen J; van Leenen D; von der Möhlen M; Levi M; ten Cate H; Gallati H; ten Cate JW; van Deventer SJ
J Infect Dis; 1993 Oct; 168(4):955-60. PubMed ID: 8397270
[TBL] [Abstract][Full Text] [Related]
26. Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes.
Joyce DA; Gibbons DP; Green P; Steer JH; Feldmann M; Brennan FM
Eur J Immunol; 1994 Nov; 24(11):2699-705. PubMed ID: 7957562
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-4, interleukin-10, and soluble tumor necrosis factor receptors in cord blood.
Hata T; Kawamura T; Fujiwaki R; Aoki S; Hata K; Inada K
Gynecol Obstet Invest; 1997; 43(3):155-7. PubMed ID: 9127126
[TBL] [Abstract][Full Text] [Related]
28. Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia.
Spinas GA; Keller U; Brockhaus M
J Clin Invest; 1992 Aug; 90(2):533-6. PubMed ID: 1322942
[TBL] [Abstract][Full Text] [Related]
29. Increased concentrations of tumour necrosis factor (TNF) and soluble TNF receptors in biliary obstruction in mice; soluble TNF receptors as prognostic factors for mortality.
Bemelmans MH; Greve JW; Gouma DJ; Buurman WA
Gut; 1996 Mar; 38(3):447-53. PubMed ID: 8675101
[TBL] [Abstract][Full Text] [Related]
30. High levels of serum interleukin-10 and tumor necrosis factor-alpha are associated with fatality in fulminant hepatitis.
Nagaki M; Iwai H; Naiki T; Ohnishi H; Muto Y; Moriwaki H
J Infect Dis; 2000 Oct; 182(4):1103-8. PubMed ID: 10979906
[TBL] [Abstract][Full Text] [Related]
31. Interleukin 1 (IL-1) receptor antagonist, soluble tumor necrosis factor receptors, IL-1 beta, and IL-8--markers of remission in rheumatoid arthritis during treatment with methotrexate.
Seitz M; Loetscher P; Dewald B; Towbin H; Rordorf C; Gallati H; Gerber NJ
J Rheumatol; 1996 Sep; 23(9):1512-6. PubMed ID: 8877917
[TBL] [Abstract][Full Text] [Related]
32. [Soluble cytokinin receptors in renal vasculitis and lupus nephritis].
Tesar V; Jirsa M; Masek Z; Bartůnková J; Stejskalová A; Dostál C; Zabka J; Chábová V; Rysavá R
Cas Lek Cesk; 1998 May; 137(9):271-5. PubMed ID: 9650355
[TBL] [Abstract][Full Text] [Related]
33. The cytokines IL-1beta and IL-1 receptor antagonist, IL-2 and IL-2 soluble receptor-alpha, IL-6 and IL-6 soluble receptor, TNF-alpha and TNF soluble receptor I, and IL10 in drained and systemic blood after major orthopaedic surgery.
Krohn CD; Reikerås O; Aasen AO
Eur J Surg; 1999 Feb; 165(2):101-9. PubMed ID: 10192566
[TBL] [Abstract][Full Text] [Related]
34. Induction of circulating and erythrocyte-bound IL-8 by IL-2 immunotherapy and suppression of its in vitro production by IL-1 receptor antagonist and soluble tumor necrosis factor receptor (p75) chimera.
Tilg H; Shapiro L; Atkins MB; Dinarello CA; Mier JW
J Immunol; 1993 Sep; 151(6):3299-307. PubMed ID: 8397255
[TBL] [Abstract][Full Text] [Related]
35. Tumor necrosis factor alpha and interleukin-1 alpha stimulate late shedding of p75 TNF receptors but not p55 TNF receptors from human monocytes.
Joyce DA; Steer JH
J Interferon Cytokine Res; 1995 Nov; 15(11):947-54. PubMed ID: 8590306
[TBL] [Abstract][Full Text] [Related]
36. Serum levels of tumor necrosis factor (TNF), soluble receptors for TNF (55- and 75-kDa sTNFr), and soluble CD14 (sCD14) in epithelial ovarian cancer.
Gadducci A; Ferdeghini M; Castellani C; Annicchiarico C; Gagetti O; Prontera C; Bianchi R; Facchini V
Gynecol Oncol; 1995 Aug; 58(2):184-8. PubMed ID: 7542621
[TBL] [Abstract][Full Text] [Related]
37. Persistent systemic inflammatory response after stent insertion in patients with malignant bile duct obstruction.
Ballinger AB; Woolley JA; Ahmed M; Mulcahy H; Alstead EM; Landon J; Clark ML; Farthing MJ
Gut; 1998 Apr; 42(4):555-9. PubMed ID: 9616320
[TBL] [Abstract][Full Text] [Related]
38. Increase of sTNF receptor levels in acute renal allograft rejection after treatment with OKT3.
Bemelman FJ; Jansen J; van der Poll T; van Deventer SJ; ten Berge RJ
Nephrol Dial Transplant; 1994; 9(12):1786-90. PubMed ID: 7708265
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-1 beta induces interleukin-1 receptor antagonist and tumor necrosis factor binding protein in humans.
Bargetzi MJ; Lantz M; Smith CG; Torti FM; Olsson I; Eisenberg SP; Starnes HF
Cancer Res; 1993 Sep; 53(17):4010-3. PubMed ID: 8395334
[TBL] [Abstract][Full Text] [Related]
40. Chronological changes in circulating levels of soluble tumor necrosis factor receptors 1 and 2 in rats with carbon tetrachloride-induced liver injury.
Ijiri Y; Kato R; Sadamatsu M; Takano M; Okada Y; Tanaka K; Hayashi T
Toxicology; 2014 Feb; 316():55-60. PubMed ID: 24389507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
